Research ArticleOpen Access

Treatment of Lower Back Pain with Bone Marrow Concentrate

Volume 7 - Issue 2

**Marc Darrow* and Brent Shaw BS**

Author Information Open or Close
- Darrow Stem Cell Institute, USA
*Corresponding author: Marc Darrow, Darrow Stem Cell Institute, 11645 Wilshire Boulevard Suite 120, Los Angeles, CA 90025, USA

Received: July 12, 2018; Published: July 23, 2018

DOI: 10.26717/BJSTR.2018.07.001461

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Lower back pain can be a debilitating condition that is often caused by ligament and fascial sprains, and muscle strains. Even though the diagnosis may be a herniated disc, facet arthropathy, degenerative disc disease, spinal stenosis, scoliosis, spondylosis, spondylolisthesis, or other pathology, we have found for the past twenty years, with thousands of successfully treated patients, that the actual pain generator may not even be noted in the diagnosis. With the risk of adverse complications of surgery and ineffectiveness of epidural injections, bone marrow concentrate (BMC) offers a promising treatment to treat lower back pain. BMC contains mesenchymal stem cells that have the ability to differentiate into muscle, cartilage, and bone, in addition to releasing trophic factors that enhance tissue regeneration. The four patients included in this study underwent at least one treatment of BMC injection to the entheses of muscles, fascia, and ligaments surrounding the lumbar spine. At one-year follow-up all four patients experienced a decrease in resting and active pain. Patients also reported a mean 80% total overall improvement and were able to perform daily activities with less difficulty. These encouraging results warrant further investigation of the full potential of BMC injections for lower back pain.

Keywords: Stem Cells; Lower Back Pain; Non-Operative Treatment